Latest period
$8.17B
YoY change
+27.8%
5Y CAGR
+20.1%
Peak year (2025)
$8.07B
Latest annual
$8.07B
Dividends Paid history chart for Novo Nordisk (NVO) from 1990 to 2025
Latest: $8.07B
Dividends Paid growth chart for Novo Nordisk (NVO) from 1990 to 2025
Latest: +27.8%
Dividends Paid history table for Novo Nordisk (NVO) from 1990 to 2025
| 2025 | $8.07B | +27.8% | +$1.76B | ||
| 2024 | $6.31B | +37.7% | +$1.73B | ||
| 2023 | $4.59B | +31.9% | +$1.11B | ||
| 2022 | $3.48B | +5.1% | +$168.83M | ||
| 2021 | $3.31B | +2.6% | +$82.75M | ||
| 2020 | $3.23B | +12.1% | +$348.58M | ||
| 2019 | $2.88B | -1.2% | −$35.58M | ||
| 2018 | $2.91B | -2.3% | −$69.77M | ||
| 2017 | $2.98B | -13.6% | −$471.15M | ||
| 2016 | $3.45B | +82.3% | +$1.56B | ||
| 2015 | $1.89B | -4.9% | −$96.66M | ||
| 2014 | $1.99B | +12.3% | +$217.74M | ||
| 2013 | $1.77B | +31.7% | +$426.54M | ||
| 2012 | $1.35B | +30.5% | +$314.54M | ||
| 2011 | $1.03B | +28.8% | +$230.77M | ||
| 2010 | $801.49M | +10.7% | +$77.30M | ||
| 2009 | $724.19M | +46.2% | +$228.98M | ||
| 2008 | $495.21M | +14.8% | +$63.74M | ||
| 2007 | $431.47M | +28.2% | +$94.93M | ||
| 2006 | $336.54M | +32.4% | +$82.39M | ||
| 2005 | $254.15M | -2.2% | −$5.83M | ||
| 2004 | $259.98M | +25.9% | +$53.56M | ||
| 2003 | $206.42M | — | — | ||
| 2002 | — | — | — | ||
| 2001 | — | — | — | ||
| 2000 | — | — | — | ||
| 1999 | — | — | — | ||
| 1998 | — | — | — | ||
| 1997 | — | — | — | ||
| 1996 | — | — | — | ||
| 1995 | — | — | — | ||
| 1994 | — | — | — | ||
| 1993 | — | — | — | ||
| 1992 | — | — | — | ||
| 1991 | — | — | — | ||
| 1990 | — | — | — |
- 2025$8.07B+27.8%
- 2024$6.31B+37.7%
- 2023$4.59B+31.9%
- 2022$3.48B+5.1%
- 2021$3.31B+2.6%
- 2020$3.23B+12.1%
- 2019$2.88B-1.2%
- 2018$2.91B-2.3%
- 2017$2.98B-13.6%
- 2016$3.45B+82.3%
- 2015$1.89B-4.9%
- 2014$1.99B+12.3%
- 2013$1.77B+31.7%
- 2012$1.35B+30.5%
- 2011$1.03B+28.8%
- 2010$801.49M+10.7%
- 2009$724.19M+46.2%
- 2008$495.21M+14.8%
- 2007$431.47M+28.2%
- 2006$336.54M+32.4%
- 2005$254.15M-2.2%
- 2004$259.98M+25.9%
- 2003$206.42M—
- 2002——
- 2001——
- 2000——
- 1999——
- 1998——
- 1997——
- 1996——
- 1995——
- 1994——
- 1993——
- 1992——
- 1991——
- 1990——
Dividends Paid values are taken from Novo Nordisk's reported cash flow statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About Dividends Paid at Novo Nordisk (NVO)
Dividends Paid for Novo Nordisk (NVO): headline value $8.17B · YoY +27.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Novo Nordisk (NVO) dividends paid totalled 51.76B DKK – grew 17.3% year-over-year.
Over 2020–2025 (5 years), Novo Nordisk dividends paid expanded at a +20.8% compound annual rate, sustaining 8 straight years of year-over-year growth.
Across the available history, dividends paid reached its high of 51.76B DKK in 2025 and its low of 0.00 DKK in 1990.
Novo Nordisk Dividends Paid by Year
Novo Nordisk Dividends Paid 2025: $8.07B
Novo Nordisk dividends paid in 2025 was 51.76B DKK ($8.07B), grew 17.3% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Dividends Paid 2024: $6.31B
2024's dividends paid for Novo Nordisk came in at 44.14B DKK ($6.31B), surged 38.9% from 2023.
Novo Nordisk Dividends Paid 2023: $4.59B
Novo Nordisk posted dividends paid of 31.77B DKK ($4.59B) in 2023, grew 25.5% from 2022.
Novo Nordisk Dividends Paid 2022: $3.48B
In 2022, Novo Nordisk reported dividends paid of 25.30B DKK ($3.48B), grew 17.6% from 2021.
Novo Nordisk Dividends Paid 2021: $3.31B
Novo Nordisk dividends paid in 2021 was 21.52B DKK ($3.31B).
See more financial history for Novo Nordisk (NVO).
Sector peers by Dividends Paid
Healthcare peers of Novo Nordisk (NVO), ranked by their latest dividends paid
| $12.38B | |
| $11.66B | |
| $8.18B | |
| $7.92B | |
| $5.38B | |
| $5.12B | |
| $5.08B | |
| $636.00M |
- $12.38B
- $11.66B
- $8.18B
- $7.92B
- $5.38B
- $5.12B
- $5.08B
- $636.00M
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation